Cigna Group
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
CI$295.60+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FS-4
STATEMENTS OF CASH FLOWS
| For the Years Ended December 31, | |||
|---|---|---|---|
| (In millions) | 2024 | 2023 | 2022 |
| Cash Flows from Operating Activities | |||
| Shareholders' net income | $3,434 | $5,164 | $6,704 |
| Adjustments to reconcile shareholders' net income | |||
| to net cash provided by operating activities | |||
| Equity in income of subsidiaries | (4,154) | (5,886) | (7,402) |
| Dividends received from subsidiaries | 2,916 | 1,381 | 2,056 |
| Other liabilities | (306) | 540 | 5 |
| Other, net | 243 | 640 | 298 |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 2,133 | 1,839 | 1,661 |
| Cash Flows from Investing Activities | |||
| Net change in amounts due from affiliates | — | 622 | (901) |
| Net proceeds from short-term investments sold | — | — | 99 |
| NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES | — | 622 | (802) |
| Cash Flows from Financing Activities | |||
| Net change in amounts due to affiliates | 4,761 | 1,473 | 10,392 |
| Net change in commercial paper | (357) | 1,237 | (2,027) |
| Repayment of long-term debt | (2,731) | (2,822) | (430) |
| Net proceeds on issuance of long-term debt | 4,462 | 1,491 | — |
| Issuance of common stock | 305 | 187 | 389 |
| Common dividends paid | (1,567) | (1,450) | (1,384) |
| Repurchase of common stock | (7,034) | (2,284) | (7,607) |
| Tax withholding on stock compensation and other | (117) | (110) | (73) |
| NET CASH USED IN FINANCING ACTIVITIES | (2,278) | (2,278) | (740) |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (145) | 183 | 119 |
| Cash, cash equivalents and restricted cash, beginning of year | 335 | 152 | 33 |
| Cash, cash equivalents and restricted cash, end of year (1) | $190 | $335 | $152 |
| Noncash Investing and Financing Activities: | |||
| Net amounts due from affiliates settled through capital transactions | (7,565) | (5,221) | (5,037) |
(1) Includes restricted cash reported in Other non-current assets.
FS-4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.